Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.51-0.12 (-1.03%)
At close: 04:00PM EDT
11.75 +0.24 (+2.09%)
After hours: 05:07PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
48,886
23,028
135,082
19,886
13,469
Operating Expense
113,834
112,111
129,697
131,565
90,851
Operating Income
-67,029
-89,083
5,385
-111,679
-77,382
Other Income Expense
679
642
2,334
4,490
2,980
Pretax Income
-66,350
-88,441
7,719
-107,189
-74,402
Tax Provision
-
0
-691
-816
-389
Net Income Common Stockholders
-66,350
-88,441
8,410
-106,373
-74,013
Diluted NI Available to Com Stockholders
-66,350
-88,441
8,410
-106,373
-74,013
Basic EPS
-
-1.74
0.18
-2.49
-2.06
Diluted EPS
-
-1.74
0.18
-2.49
-2.06
Basic Average Shares
-
50,719
47,413
42,669
35,893
Diluted Average Shares
-
50,719
47,915
42,669
35,893
Total Operating Income as Reported
-67,029
-89,083
5,385
-111,679
-77,382
Total Expenses
115,915
112,111
129,697
131,565
90,851
Net Income from Continuing & Discontinued Operation
-66,350
-88,441
8,410
-106,373
-74,013
Normalized Income
-66,350
-88,441
8,410
-106,373
-74,013
EBIT
-67,029
-89,083
5,385
-111,679
-77,382
EBITDA
-66,779
-
-
-
-
Reconciled Depreciation
250
248
209
198
370
Net Income from Continuing Operation Net Minority Interest
-66,350
-88,441
8,410
-106,373
-74,013
Normalized EBITDA
-66,779
-88,835
5,594
-111,481
-77,012
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement